All In Biotech

Drug Trial Radar · NCT02607904

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

A Phase 2, Double-blind, Randomized, Placebo-controlled Pharmacokinetic Trial in 2 Parallel Groups to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and GWP42003-P in Patients With Epilepsy

Last checked: Nov 19, 2026Latest source record: Dec 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Dec 15, 2016

Primary completion

May 27, 2019

Study completion May 27, 2019

Sponsor

Lead sponsor
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
Sponsor type
Industry
First posted
Nov 18, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 16 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The open-label extension phase only will be described in this record. All participants will receive the same dose of GWP42003-P. However, investigators may subsequently decrease or increase the participant's dose until the optimal dose is found.

Conditions

  • Epilepsy

Interventions

  • GWP42003-PDrug

    Clear, colorless to yellow solution containing cannabidiol (CBD) dissolved in the excipients sesame oil and anhydrous ethanol with added sweetener (sucralose) and strawberry flavoring.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants who experienced an adverse event.Time frame: Up to 48 weeks.

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • SEIN - Epilepsy Institute in the Netherlands Foundation

    Zwolle, Netherlands

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Ruber Internacional

    Madrid, Spain

  • Hospital Universitario Virgen del Rocio

    Seville, Spain

  • Sahlgrenska University Hospital

    Gothenburg, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.